Short Interest in P3 Health Partners Inc. (NASDAQ:PIII) Increases By 32.8%

P3 Health Partners Inc. (NASDAQ:PIII) saw a large growth in short interest in the month of December. As of December 31st, there was short interest totaling 24,688 shares, a growth of 32.8% from the December 15th total of 18,589 shares. Based on an average daily trading volume, of 16,172 shares, the short-interest ratio is presently 1.5 days. Approximately 0.4% of the company’s stock are sold short. Approximately 0.4% of the company’s stock are sold short. Based on an average daily trading volume, of 16,172 shares, the short-interest ratio is presently 1.5 days.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on PIII shares. Lake Street Capital reduced their price objective on P3 Health Partners from $20.00 to $12.50 and set a “buy” rating on the stock in a research note on Monday, November 17th. Weiss Ratings restated a “sell (e+)” rating on shares of P3 Health Partners in a report on Wednesday, October 8th. Finally, BTIG Research reiterated a “neutral” rating on shares of P3 Health Partners in a research note on Friday, December 12th. One equities research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $12.50.

P3 Health Partners Stock Down 3.0%

NASDAQ:PIII traded down $0.10 during trading hours on Friday, hitting $3.20. The company’s stock had a trading volume of 34,064 shares, compared to its average volume of 13,804. The stock has a market capitalization of $23.07 million, a P/E ratio of -0.08 and a beta of 0.90. The company has a current ratio of 0.32, a quick ratio of 0.32 and a debt-to-equity ratio of 2.29. The stock has a fifty day moving average of $4.77 and a 200-day moving average of $6.81. P3 Health Partners has a 52-week low of $2.87 and a 52-week high of $12.44.

P3 Health Partners (NASDAQ:PIII) last released its quarterly earnings data on Thursday, November 13th. The company reported ($9.67) EPS for the quarter, missing analysts’ consensus estimates of ($8.70) by ($0.97). The business had revenue of $345.25 million during the quarter, compared to analysts’ expectations of $346.64 million. P3 Health Partners had a negative net margin of 9.07% and a negative return on equity of 302.33%. On average, equities analysts forecast that P3 Health Partners will post -0.67 earnings per share for the current year.

Institutional Trading of P3 Health Partners

An institutional investor recently raised its position in P3 Health Partners stock. Trinity Financial Advisors LLC lifted its stake in P3 Health Partners Inc. (NASDAQ:PIII) by 4.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,678 shares of the company’s stock after buying an additional 1,178 shares during the period. Trinity Financial Advisors LLC owned approximately 0.37% of P3 Health Partners worth $239,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 7.75% of the company’s stock.

P3 Health Partners Company Profile

P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.

The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.